Pharmaceutical industry is navigating an inflection point characterized by profound scientific advancement juxtaposed against unsustainable translational inefficiencies.For decades,the foundational paradigm of antican...Pharmaceutical industry is navigating an inflection point characterized by profound scientific advancement juxtaposed against unsustainable translational inefficiencies.For decades,the foundational paradigm of anticancer drug development has relied on in vivo animal models to assess pharmacodynamics,efficacy,and safety prior to human trials.展开更多
Use of animals in biomedical research is still considered essential by many in aca-demia,industry and regulatory authorities.Therefore,it is important that legal,gov-ernance and welfare procedures are in place to ensu...Use of animals in biomedical research is still considered essential by many in aca-demia,industry and regulatory authorities.Therefore,it is important that legal,gov-ernance and welfare procedures are in place to ensure that only necessary procedures using animals are carried out and that this occurs within a framework with animal welfare at its core.Animal research in the United Kingdom is conducted under the Animals(Scientific Procedures)Act 1986 and animal research in the United Kingdom has long been seen as a flag bearer for high quality-high welfare research.An example of the leading role taken in supporting animal welfare in research was establishment of the National Centre for the Replacement,Refinement and Reduction of Animals in Research(NC3Rs)to support reducing the scale and impact of animal research.Here,we provide an overview of governance and licensing procedures of animal research in the United Kingdom,coupled with explanations of how excellent welfare underpins high quality research,and examine the development of new approach methodologies.展开更多
基金supported by the National Natural Science Foundation of China(82272953)the National Key Research and Development Program of China(2023YFC2508500).
摘要Pharmaceutical industry is navigating an inflection point characterized by profound scientific advancement juxtaposed against unsustainable translational inefficiencies.For decades,the foundational paradigm of anticancer drug development has relied on in vivo animal models to assess pharmacodynamics,efficacy,and safety prior to human trials.
摘要Use of animals in biomedical research is still considered essential by many in aca-demia,industry and regulatory authorities.Therefore,it is important that legal,gov-ernance and welfare procedures are in place to ensure that only necessary procedures using animals are carried out and that this occurs within a framework with animal welfare at its core.Animal research in the United Kingdom is conducted under the Animals(Scientific Procedures)Act 1986 and animal research in the United Kingdom has long been seen as a flag bearer for high quality-high welfare research.An example of the leading role taken in supporting animal welfare in research was establishment of the National Centre for the Replacement,Refinement and Reduction of Animals in Research(NC3Rs)to support reducing the scale and impact of animal research.Here,we provide an overview of governance and licensing procedures of animal research in the United Kingdom,coupled with explanations of how excellent welfare underpins high quality research,and examine the development of new approach methodologies.